Enhancing taxol delivery with novel taxol conjugated liposomal nanoparticles

Cancer has been a leading cause of death in many developed nations. Although there exists a variety of anti-cancer drugs, standard chemotherapy has a severe limitation in which all dividing cells are been targeted as well. In order to enhance the efficiency of anti-cancer drug delivery, we adopt a n...

Full description

Bibliographic Details
Main Author: Soh, Hua Xiang.
Other Authors: Liao Kin
Format: Final Year Project (FYP)
Language:English
Published: 2011
Subjects:
Online Access:http://hdl.handle.net/10356/45283
_version_ 1811678897374232576
author Soh, Hua Xiang.
author2 Liao Kin
author_facet Liao Kin
Soh, Hua Xiang.
author_sort Soh, Hua Xiang.
collection NTU
description Cancer has been a leading cause of death in many developed nations. Although there exists a variety of anti-cancer drugs, standard chemotherapy has a severe limitation in which all dividing cells are been targeted as well. In order to enhance the efficiency of anti-cancer drug delivery, we adopt a nano-particle mediated approach whereby targeted anti-cancer therapeutics will be conjugated to biodegradable nano-particles. Due to the extra-permeability and retention (EPR) effect, the nano-particles will be entrapped in the solid tumors, but not in healthy tissues. The conjugated anti-cancer therapeutics will then be released and destroy the cancer cells. Possible improvements will include the use of selective signaling pathway inhibitors to inhibit cancer cell division, and the conjugation of selective ligands to improve the targeting ability of the nano-particles.
first_indexed 2024-10-01T03:00:33Z
format Final Year Project (FYP)
id ntu-10356/45283
institution Nanyang Technological University
language English
last_indexed 2024-10-01T03:00:33Z
publishDate 2011
record_format dspace
spelling ntu-10356/452832023-03-03T15:32:47Z Enhancing taxol delivery with novel taxol conjugated liposomal nanoparticles Soh, Hua Xiang. Liao Kin School of Chemical and Biomedical Engineering Sudipta Basu DRNTU::Engineering::Nanotechnology Cancer has been a leading cause of death in many developed nations. Although there exists a variety of anti-cancer drugs, standard chemotherapy has a severe limitation in which all dividing cells are been targeted as well. In order to enhance the efficiency of anti-cancer drug delivery, we adopt a nano-particle mediated approach whereby targeted anti-cancer therapeutics will be conjugated to biodegradable nano-particles. Due to the extra-permeability and retention (EPR) effect, the nano-particles will be entrapped in the solid tumors, but not in healthy tissues. The conjugated anti-cancer therapeutics will then be released and destroy the cancer cells. Possible improvements will include the use of selective signaling pathway inhibitors to inhibit cancer cell division, and the conjugation of selective ligands to improve the targeting ability of the nano-particles. Bachelor of Engineering (Chemical and Biomolecular Engineering) 2011-06-10T07:10:14Z 2011-06-10T07:10:14Z 2011 2011 Final Year Project (FYP) http://hdl.handle.net/10356/45283 en Nanyang Technological University 115 p. application/pdf
spellingShingle DRNTU::Engineering::Nanotechnology
Soh, Hua Xiang.
Enhancing taxol delivery with novel taxol conjugated liposomal nanoparticles
title Enhancing taxol delivery with novel taxol conjugated liposomal nanoparticles
title_full Enhancing taxol delivery with novel taxol conjugated liposomal nanoparticles
title_fullStr Enhancing taxol delivery with novel taxol conjugated liposomal nanoparticles
title_full_unstemmed Enhancing taxol delivery with novel taxol conjugated liposomal nanoparticles
title_short Enhancing taxol delivery with novel taxol conjugated liposomal nanoparticles
title_sort enhancing taxol delivery with novel taxol conjugated liposomal nanoparticles
topic DRNTU::Engineering::Nanotechnology
url http://hdl.handle.net/10356/45283
work_keys_str_mv AT sohhuaxiang enhancingtaxoldeliverywithnoveltaxolconjugatedliposomalnanoparticles